HanchorBio

Company

Last deal

$20.M

Amount

Series A

Stage

25.08.2022

Date

all rounds

$20.M

Total amount

General

About Company

HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.

Also Known As

Hankang Biotechnology, Hanke Bio

founded date

2020

Number of employees

11-50

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Developer of drugs intended to treat cancer. The company specializes in the drug discovery based on tumor immunology, committing to improving the life quality of patients with cancer.

Contacts

location

Taipei City, Taiwan

Phone number

+8860227921366

Website URL

https://hanchorbio.com/